Medlab Asia,colocatied with Asia Health, the premiere lab event of the ASEAN region,and will be held in Bangkok, Thailand from August 16th to 18th very soon in 2023.
VACURE Biotech sincerely invites you, from global manufacturers to established laboratory suppliers, to witness the latest developments in the medical laboratory and medical diagnostic industries, and have the opportunity to communicate with the most famous companies and professionals in the industry at the exhibition Interact and share innovative technological achievements, and jointly bring infinite wonderful possibilities to the development of the global medical market!
VACURE Biotech, as a leading enterprise in China's maternal and child rapid diagnosis industry, will present two fluorescent immunoassay platforms LYOFIA® and DISKFLU® independently developed by independent innovation at this event, covering pre-pregnancy, early pregnancy, second trimester, late pregnancy and children's growth and development, to provide rapid detection and diagnosis solutions for the whole pregnancy process, and facilitate precision medicine.
Products at a glance
Part 1 LYOFIA® platform
|
|
LYOFIA-I |
| Small and Fast | |
| · Single Channel | |
| · Equipped with an incubator |
| LYOFIA8 |
|
| Small and Portable | |
| · 8 Channels,8 samples at a time | |
| · 96 test/h | |
| · Built-in incubator | |
| · Support continuous sample processing |
Part 2 DISKFLU® Platform
|
|
DISKFLU |
| Small but Smart | |
| · Single Channel | |
| · Self-contained centrifuge | |
| · 15mins,Detecte 9 parameters |
Part 3 Local Characteristic Gifts
About VACURE Biotech
VACURE Biotech is a high-tech enterprise focusing on the field of in vitro diagnostic (IVD) point-of-care testing (POCT). The company has gathered a large number of R&D personnel (accounting for 39%) such as the Provincial Thousand Talents Program. Based on self-developed patented core technologies such as microfluidic chip design, time-resolved fluorescent nanomaterials, and inkjet freeze-drying, through a number of underlying technological innovations, independent The fluorescent immunoassay quantitative detection platform LYOFIA system has been developed, the DISKFLU disc microfluidic immunological joint detection chip system has been iteratively upgraded, and the GENFLU microfluidic molecular integrated POCT detection system has been deployed to create POCT immunological and molecular products with excellent performance, realizing raw materials, instruments and The whole chain of reagents is self-developed and self-produced. Since 2023, the products have been exported to 50+ countries at home and abroad.
VACURE Biotech will conduct close exchanges and discussions with global customers and partners, further accelerate the pace of internationalization strategy, and open another new chapter, so stay tuned!
Booth No. : H6.F23
Date: 16-18,August
Location: IMPACT Exhibition
Don't miss out on the chance to be a part of this essential industry event and help shape the future of health.